Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 12322913Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2025Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2025 award categories
- Internal Medicine
NIH Funding · FY2025
Linked Award Amount
$272.8K
Full award amounts, FY2025
Award Records
2
Records listing this PI
Award-Linked Rank
#42,416
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2025 award records by amount
NIH award records listing Eleni Tiniakou as a PI. Multi-PI records show the full award amount for context.
- 7K08AR077732-05K08RNA: Polymerase III specific CD8+ T cells: a mechanistic insight into cancer-induced autoimmunity in scleroderma$158.7Kaward amount
- 5R21AR083566-02R21The MIGHT Trial - An Exploratory Clinical Trial of IVIG in anti-HMGCR ImmuneMediated Necrotizing Myopathy$114Kaward amount
Award organizations
Organizations that administered FY2025 awards listing Eleni Tiniakou as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardUT Health Science Center Houston
- 2024$500K Cumulative Funding
- 2025$1M Cumulative Funding
- 2025Multi-Institutional ResearchAwards at 2 institutions
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Eleni Tiniakou.